RIZATRIPTAN BENZOATE FAST DISSOLVING TABLETS FOR QUICK RELIEVE OF MIGRAINE: DESIGN, DEVELOPMENT AND CHARACTERIZATION
Objective: Rizatriptan benzoate (RB) is a new generation anti-migraine drug. After oral administration, the peak plasma concentrations (tmax) occur in about 1 to 2.5 hrs depending on the formulation and the bioavailability which is about 40 to 45%. Food may delay the tmax by about 1 hour. The aim o...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Al-Azhar University, Faculty of Pharmacy
2014-09-01
|
| Edice: | Al-Azhar Journal of Pharmaceutical Sciences |
| Témata: | |
| On-line přístup: | https://ajps.journals.ekb.eg/article_6949_f99746ff1973f0b4fdce5000bb13cbd8.pdf |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|